Latest Regulatory Approvals News

Predictive Discovery has secured a crucial court approval for its acquisition of Robex Resources, paving the way for the deal to close in early 2026 pending final regulatory consents.

Brightstar Resources has secured key regulatory approvals for the Lady Shenton open pit mine in Menzies, positioning the company to accelerate production within its Goldfields Hub. The deposit is now 'mine ready' and will feed into Brightstar’s planned Laverton processing plant.

The Foreign Investment Review Board has extended its deadline to assess Caterpillar’s proposed acquisition of RPMGlobal, pushing the decision to 23 January 2026. This procedural extension keeps the deal on track but leaves some questions open for shareholders.

McLaren Minerals’ Pre-Feasibility Study confirms a robust, low-risk titanium mining project in Western Australia, projecting nearly A$900 million EBITDA over 16 years. The study highlights strong market demand and validated processing methods, setting the stage for the next development phase.

RareX Limited has achieved a major regulatory milestone with the granting of a Mining Lease for its Cummins Range Project in Western Australia, significantly reducing development risk and paving the way for focused metallurgical optimisation and mine planning.

Horizon Oil has approved a strategic $1.5 million investment to install a booster compressor at its Nam Phong gas field in Thailand, aiming to increase production by at least 40% by mid-2026.

Tetratherix has successfully completed the second safety review of its TetraDerm clinical trial's second cohort, showing no adverse events and confirming a strong safety profile. The trial now progresses to its final phase, targeting a growing reconstructive surgery market.

Miramar Resources is set to launch a multi-commodity drilling campaign in early 2026, focusing on gold targets near Kalgoorlie and high-grade copper-lead-silver mineralisation in the Gascoyne region.

Lunnon Metals reports standout drilling results at Lady Herial, revealing thick, high-grade gold mineralisation beyond current open pit plans and setting the stage for expanded mining activity.

Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.